{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:46:43Z","timestamp":1771019203952,"version":"3.50.1"},"reference-count":59,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,8,19]],"date-time":"2011-08-19T00:00:00Z","timestamp":1313712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[2011,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multicenter clinical trials have established new standards of care in the surgical and medical management of malignant melanoma. They have led to the testing of new therapies and improved outcomes for patients with loco\u2010regional and distant disease. Many pressing questions remain, however, and additional multicenter trials are currently underway to address them. The purpose of this review is to summarize relevant ongoing and planned multicenter trials that have and continue to define current melanoma management. J. Surg. Oncol. 2011; 104:430\u2013437. \u00a9 2011 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jso.21867","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T04:20:00Z","timestamp":1407817200000},"page":"430-437","source":"Crossref","is-referenced-by-count":7,"title":["Current and planned multicenter trials for patients with primary or metastatic melanoma"],"prefix":"10.1002","volume":"104","author":[{"given":"Vernon K.","family":"Sondak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremiah","family":"Deneve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragini","family":"Kudchadkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,8,19]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2005.00045.x"},{"key":"e_1_2_7_3_2","first-page":"CD004835","article-title":"Surgical excision margins for primary cutaneous melanoma","volume":"4","author":"Sladden MJ","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20084"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2010.115"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0858-x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060992"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1203-0"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2003.07.012"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9099-4"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.2342"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.063"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.009"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.4573"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0183-9"},{"key":"e_1_2_7_16_2","doi-asserted-by":"crossref","first-page":"LBA9084","DOI":"10.1200\/jco.2009.27.18_suppl.lba9084","article-title":"Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: Results of an intergroup randomized trial","volume":"27","author":"Henderson M","year":"2009","journal-title":"J Clin Oncol"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11947"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2010.09.005"},{"key":"e_1_2_7_19_2","first-page":"669","volume-title":"Cutaneous Melanoma","author":"Kirkwood JM","year":"2009"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.1.7"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1103-3"},{"key":"e_1_2_7_22_2","doi-asserted-by":"crossref","first-page":"612s","DOI":"10.1200\/jco.2010.28.15_suppl.8505","article-title":"Randomized phase III trial comparing postoperative adjuvant ganglioside GM2\u2010KLH\/QS\u201021 vaccination versus observation in stage II (T3\u2010T4N0M0) melanoma: Final results of study EORTC 18961","volume":"28","author":"Eggermont A","year":"2010","journal-title":"J Clin Oncol"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.12.2444"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67482-X"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.185"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.3121"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.1704"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2010.09.001"},{"key":"e_1_2_7_29_2","article-title":"Pharmacokinetic\/pharmacodynamic analysis of adjuvant pegylated interferon \u03b1\u20102b in patients with resected high\u2010risk melanoma","author":"Daud AI","journal-title":"Cancer Chemother Pharmacol"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61033-8"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22427"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.5344"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0037"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni0702-611"},{"key":"e_1_2_7_35_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/PPO.0b013e3181a7450f","article-title":"Recent advances using anti\u2010CTLA\u20104 for the treatment of melanoma","volume":"15","author":"Sarnaik AA","year":"2009","journal-title":"Cancer J"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0104-y"},{"key":"e_1_2_7_38_2","doi-asserted-by":"crossref","first-page":"612s","DOI":"10.1200\/jco.2010.28.15_suppl.8504","article-title":"E4697: Phase III cooperative group study of yeast\u2010derived granulocyte macrophage colony\u2010stimulating factor (GM\u2010CSF) versus placebo as adjuvant treatment of patients with completely resected stage III\u2010IV melanoma","volume":"28","author":"Lawson D","year":"2010","journal-title":"J Clin Oncol"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2555"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.01.151"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2013.04.009"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200403000-00013"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2005.12.003"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2007.04.007"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26111"},{"key":"e_1_2_7_46_2","first-page":"543","article-title":"Regression of malignant melanoma as a manifestation of a cellular immunity response","volume":"62","author":"Lloyd OC:","year":"1969","journal-title":"Proc R Soc Med"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.2.100"},{"key":"e_1_2_7_48_2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CMR.0b013e3283390711","article-title":"A phase 2 study of high\u2010dose Allovectin\u20107 in patients with advanced metastatic melanoma","volume":"20","author":"Bedikian AY","year":"2010","journal-title":"Melanoma Res"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0b013e32831328c7"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2000.0130"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.3675"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2010.495383"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1100"},{"key":"e_1_2_7_54_2","first-page":"589","volume-title":"Cutaneous Melanoma","author":"Atkins MB:","year":"2003"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002011"},{"key":"e_1_2_7_56_2","first-page":"643","article-title":"c\u2010KIT signaling as the driving oncogenic event in sub\u2010groups of melanomas","volume":"24","author":"Smalley KS","year":"2009","journal-title":"Histol Histopathol"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.2984"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604482"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23987"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25320"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.21867","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.21867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T02:18:52Z","timestamp":1694398732000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.21867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,19]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,9,15]]}},"alternative-id":["10.1002\/jso.21867"],"URL":"https:\/\/doi.org\/10.1002\/jso.21867","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"value":"0022-4790","type":"print"},{"value":"1096-9098","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,19]]}}}